A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in ...

The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

Discover Skye Bioscience's progress on nimacimab with early trial enrollment, extended treatment protocols, and robust regulatory plans.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

ST316, a β-catenin/BCL9 antagonist, demonstrated safety, target engagement, and early antitumor activity in advanced solid ...

Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have demonstrated the potential for a new combination therapy to improve outcomes for patients with ...

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...